Ursodeoxycholic acid has choleretic, hepatoprotective, hypoglycemic, hypolipidemic, immunomodulatory, and antitumor effects (39, 40)
It promotes osteoblast activity and angiogenesis at fracture sites, potentially shortening the time to "union" in non-weight-bearing bones
Comparative studies examining ipamorelin and GHRP-6 both demonstrated BMC increases, consistent with the known role of the GH/IGF-1 axis in bone formation, periosteal expansion, and endochondral ossification
Results vary by dose, route, baseline pigmentation, and cofactors like vitamin C
Kanchanavithayakul A, Prasittisa K, Kiat-Amornrak P, Chanda M, Kittiwatanasarn P, Nuchprayoon I, Cheepsunthorn CL